Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

The Association Between Survivin -31G/C Promoter Polymorphism and Breast Cancer in Eastern Azerbaijan, Iran

Mahdiyeh Rojhannejad 1 , * , Mohamadali Hoseinpourfeizi 2 , Naser Pouladi 3 , Mohamad Reza Arab 4 and Mahdi Mohamadi 5
Authors Information
1 Department of Genetics, Faculty of Sciences, University of Tabriz, Tabriz, IR Iran
2 Department of Biology, University of Tabriz, Tabriz, IR Iran
3 Department of Biology, Faculty of Sciences, University of Tehran, Tehran, IR Iran
4 Department of Anatomical Sciences, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
5 Department of Biostatistics, Faculty of Health, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: December 28, 2015, 17 (12); e5196
  • Published Online: December 26, 2015
  • Article Type: Research Article
  • Received: July 14, 2014
  • Accepted: December 28, 2014
  • DOI: 10.17795/zjrms-5196

To Cite: Rojhannejad M, Hoseinpourfeizi M, Pouladi N, Arab M R, Mohamadi M. The Association Between Survivin -31G/C Promoter Polymorphism and Breast Cancer in Eastern Azerbaijan, Iran, Zahedan J Res Med Sci. 2015 ; 17(12):e5196. doi: 10.17795/zjrms-5196.

Abstract
Copyright © 2015, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Peng XC, Yang L, Yang LP, Mao YQ, Yang HS, Liu JY, et al. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant. J Exp Clin Cancer Res. 2008; 27: 46[DOI][PubMed]
  • 2. Jang JS, Kim KM, Kang KH, Choi JE, Lee WK, Kim CH, et al. Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer. 2008; 60(1): 31-9[DOI][PubMed]
  • 3. Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B. Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India. Ann Surg Oncol. 2011; 18(3): 880-7[DOI][PubMed]
  • 4. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998; 58(23): 5315-20[PubMed]
  • 5. Han CH, Wei Q, Lu KK, Liu Z, Mills GB, Wang LE. Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer. Int J Clin Exp Med. 2009; 2(4): 289-99[PubMed]
  • 6. Yang X, Xiong G, Chen X, Xu X, Wang K, Fu Y, et al. Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2009; 135(10): 1341-9[DOI][PubMed]
  • 7. Yang L, Zhu H, Zhou B, Gu H, Yan H, Tang N, et al. The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci. 2009; 54(5): 1021-8[DOI][PubMed]
  • 8. Cheng ZJ, Hu LH, Huang SJ. [Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma]. Ai Zheng. 2008; 27(3): 258-63[PubMed]
  • 9. Wagner M, Schmelz K, Dorken B, Tamm I. Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia. Leuk Res. 2008; 32(7): 1054-60[DOI][PubMed]
  • 10. Xu Y, Fang F, Ludewig G, Jones G, Jones D. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 2004; 23(7): 419-29[DOI][PubMed]
  • 11. Gazouli M, Tzanakis N, Rallis G, Theodoropoulos G, Papaconstantinou I, Kostakis A, et al. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis. 2009; 24(2): 145-50[DOI][PubMed]
  • 12. Borbely AA, Murvai M, Szarka K, Konya J, Gergely L, Hernadi Z, et al. Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol. 2007; 60(3): 303-6[DOI][PubMed]
  • 13. Yang X, Xiong G, Chen X, Xu X, Wang K, Fu Y, et al. Survivin expression in esophageal cancer: correlation with p53 mutations and promoter polymorphism. Dis Esophagus. 2009; 22(3): 223-30[DOI][PubMed]
  • 14. Wang YH, Chiou HY, Lin CT, Hsieh HY, Wu CC, Hsu CD, et al. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Urology. 2009; 73(3): 670-4[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments